Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,567 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,567 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,567 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,567 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,567 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,567 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,567 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Jedrzejek David SVP and General Counsel
Sold on a plan
$44.06K 2,248 at 19.60
2.1%
Planned (10b5-1)
3 Feb 2026
Sangiovanni Timothy J. SVP, Finance & Corp Controller
Sold on a plan
$27.55K 3,000 at 9.18
9.2%
Planned (10b5-1)
3 Feb 2026
Marion Josh R. SVP and General Counsel
Sold on a plan
$26.93K 19,656 at 1.37
9.1%
Planned (10b5-1)
3 Feb 2026
Glass Ronald W. VP & Chief Accounting Officer
Sold on a plan
$26.42K 19,285 at 1.37
5.3%
Planned (10b5-1)
3 Feb 2026
Sellers Jeanette SVP of Accounting
Sold on a plan
$24.85K 1,330 at 18.68
2.8%
Planned (10b5-1)
3 Feb 2026
Sharma Manish Chief Strategy & Services Ofcr
Sold on a plan
$24.54K 98 at 250.36
1.9%
Planned (10b5-1)
3 Feb 2026
Burgum Melissa A Chief Accounting Officer
Sold on a plan
$3.76K 15 at 250.43
0.2%
Planned (10b5-1)
3 Feb 2026
Vultaggio Vincent PAO and PFO
Sold on a plan
$1.40K 556 at 2.52
0.3%
Planned (10b5-1)
2 Feb 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$10.60M 22,500 at 470.95
100%
Sold half or more
2 Feb 2026
Cochran Caroline Co-Founder, COO · indirect
Sold on a plan 10×
$10.53M 140,000 at 75.18
15.8%
Planned (10b5-1)
2 Feb 2026
McBee Brannin Chief Development Officer
Sold on a plan 6×
$9.30M 102,830 at 90.43
29.3%
Planned (10b5-1)
2 Feb 2026
LOY BERTRAND Executive Chair
Sold on a plan 6×
$7.80M 65,250 at 119.61
17.6%
Planned (10b5-1)
2 Feb 2026
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan 3×
$7.06M 85,089 at 82.93
51.5%
Sold half or more
2 Feb 2026
McBee Brannin Chief Development Officer · indirect
Sold on a plan 38×
$5.77M 63,835 at 90.44
100%
Sold half or more
2 Feb 2026
Cochran Caroline Co-Founder, COO
Sold on a plan 2×
$4.47M 60,000 at 74.45
7.5%
Planned (10b5-1)
2 Feb 2026
HUSTON BENJAMIN E. Chief Operating Officer
Sold on a plan 20×
$4.11M 10,000 at 411.27
9.2%
Planned (10b5-1)
2 Feb 2026
Howse Curtis See remarks
Sold on a plan
$3.80M 52,556 at 72.32
35.8%
Planned (10b5-1)
2 Feb 2026
Rainey John D Executive Vice President
Sold on a plan 5×
$2.45M 20,000 at 122.27
3.8%
Planned (10b5-1)
2 Feb 2026
Booth Kenneth Executive Board Member
Sold on a plan
$2.06M 4,000 at 514.00
12.5%
Planned (10b5-1)
2 Feb 2026
Kleinerman Christian EVP, Product Management
Sold on a plan
$1.97M 10,000 at 197.09
2.1%
Planned (10b5-1)
2 Feb 2026
Rummler Wendy A Chief People Officer
Sold on a plan 11×
$1.47M 2,890 at 509.20
12.5%
Planned (10b5-1)
2 Feb 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan 5×
$1.23M 7,982 at 154.59
8.6%
Planned (10b5-1)
2 Feb 2026
Hwang Donghyun Thomas SVP, Global Sales
Sold on a plan 10×
$1.19M 5,274 at 226.06
12.0%
Planned (10b5-1)
2 Feb 2026
Matsuda Masaru See Remarks
Sold on a plan 4×
$1.03M 40,638 at 25.28
27.0%
Planned (10b5-1)
2 Feb 2026
Silberstein Asaf EVP and COO
Sold on a plan
$880.00K 10,000 at 88.00
11.3%
Planned (10b5-1)
2 Feb 2026
WU Simone Senior Vice President
Sold on a plan 4×
$820.58K 8,080 at 101.56
14.2%
Planned (10b5-1)
2 Feb 2026
Miosi Salvatore A President & COO
Sold on a plan
$817.98K 30,000 at 27.27
6.2%
Planned (10b5-1)
2 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 6×
$694.31K 3,000 at 231.44
2.1%
Planned (10b5-1)
2 Feb 2026
Bernstein Harold President, R&D & CMO
Sold on a plan 4×
$690.33K 15,000 at 46.02
100%
Sold half or more
2 Feb 2026
MOEHN MICHAEL L Group President, Utilities
Sold on a plan
$673.40K 6,500 at 103.60
3.3%
Planned (10b5-1)
2 Feb 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 2×
$665.99K 9,333 at 71.36
0.5%
Planned (10b5-1)
2 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$644.82K 34,668 at 18.60
2.8%
Planned (10b5-1)
2 Feb 2026
Vohra Tajinder S Please See Remarks
Sold on a plan
$601.50K 5,756 at 104.50
35.5%
Planned (10b5-1)
2 Feb 2026
OHAYER MATTHEW EXECUTIVE CHAIRPERSON
Sold on a plan 2×
$558.14K 20,000 at 27.91
0.3%
Planned (10b5-1)
2 Feb 2026
Sold on a plan
$553.28K 2,849 at 194.20
9.2%
Planned (10b5-1)
2 Feb 2026
Watanabe Todd See Remarks
Sold on a plan
$505.71K 19,833 at 25.50
2.7%
Planned (10b5-1)
2 Feb 2026
Karam Celia Pres, Retail Bank
Sold on a plan
$460.07K 2,108 at 218.25
3.4%
Planned (10b5-1)
2 Feb 2026
Murphy Patrick Joseph Co-Chief Operating Officer
Sold on a plan
$414.73K 290 at 1,430.10
21.6%
Planned (10b5-1)
2 Feb 2026
Zimmerman Gregory E EVP & Chief Investment Officer · indirect
Sold on a plan
$404.19K 7,500 at 53.89
10.2%
Planned (10b5-1)
2 Feb 2026
Palmer Stephen R Vice President of Accounting
Sold on a plan
$393.04K 1,000 at 393.04
2.6%
Planned (10b5-1)
2 Feb 2026
Mehta Satish Chief Technology Officer
Sold on a plan
$377.25K 13,013 at 28.99
4.5%
Planned (10b5-1)
2 Feb 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$369.45K 517 at 714.60
5.1%
Planned (10b5-1)
2 Feb 2026
STETZ MATTIAS Chief Operating Officer
Sold on a plan
$353.39K 20,000 at 17.67
6.5%
Planned (10b5-1)
2 Feb 2026
O'Toole Amie Thuener VP, Chief Accounting Officer
Sold on a plan
$314.00K 933 at 336.55
8.6%
Planned (10b5-1)
2 Feb 2026
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan 2×
$305.38K 9,000 at 33.93
13.5%
Planned (10b5-1)
2 Feb 2026
Cunningham Paul Sr. Vice President
Sold on a plan
$295.09K 1,000 at 295.09
1.0%
Planned (10b5-1)
2 Feb 2026
WILLIAMS KRISTEN Chief Administrative Officer
Sold on a plan
$269.70K 13,137 at 20.53
9.1%
Planned (10b5-1)
2 Feb 2026
Howton David T Chief Operating Officer
Sold on a plan
$243.13K 37,771 at 6.44
24.4%
Planned (10b5-1)
2 Feb 2026
Bachrodt Amy SVP, Finance
Sold on a plan 3×
$230.22K 5,000 at 46.04
27.8%
Planned (10b5-1)
2 Feb 2026
Woo Raymond Chief Technology Officer
Sold on a plan 3×
$228.38K 11,112 at 20.55
6.2%
Planned (10b5-1)
Showing 8,051–8,100 of 10,567. ← Newer Page 162 of 212 Older →